Kennedy Wilson to Be Acquired by McMorrow-Led Consortium in $10.90/Share Deal

BenzingaBenzinga
|||1 min read
Key Takeaway

Kennedy Wilson agreed to be acquired by a McMorrow-led consortium and Fairfax Financial for $10.90/share, representing a 46% premium in an all-cash deal.

Kennedy Wilson to Be Acquired by McMorrow-Led Consortium in $10.90/Share Deal

Kennedy Wilson Holdings Inc. has agreed to be acquired by a consortium led by Chief Executive Officer William McMorrow and Fairfax Financial Holdings Limited in an all-cash transaction valued at $10.90 per share. The offer represents a 46% premium to the company's unaffected share price and reflects a significant valuation for the real estate and investment management firm.

Fairfax Financial has committed $1.65 billion in equity funding to support the acquisition, while McMorrow's management group will maintain operational control of the company following the transaction's completion. This ownership structure gives Fairfax majority economic interest in Kennedy Wilson while preserving continuity in the company's day-to-day management and strategic direction.

The transaction is subject to customary closing conditions, including approval from Kennedy Wilson stockholders and receipt of necessary regulatory clearances. The deal is expected to close in the second quarter of 2026, pending satisfaction of these conditions.

Source: Benzinga

Back to newsPublished Feb 17

Related Coverage

Benzinga

Mountain Commerce Bancorp Clears Regulatory Hurdles for Home BancShares Merger

Mountain Commerce Bancorp receives Federal Reserve and Arkansas regulatory approvals for merger with Home BancShares, expected to close in early Q2 2026.

HOMBMCBI
Benzinga

Smithfield Foods Surges on Robust Q4 Earnings, Nathan's Famous Deal

Smithfield Foods beat Q4 expectations with 83-cent EPS, announced $450M Nathan's Famous acquisition at $102/share, projecting $1.3-$1.5B FY26 operating profit. Stock surged 4.13%.

SFDNATH
Benzinga

Gilead Bolsters Inflammation Arsenal With $1.675B Ouro Medicines Deal

Gilead acquires Ouro Medicines for $1.675B upfront, targeting inflammation pipeline expansion. Galapagos NV partners to co-develop lead asset OM336.

GILDACLXGLPG
Benzinga

Vertiv Accelerates Capacity Push to Capitalize on AI Data Center Boom

Vertiv expands manufacturing capacity across three facilities and acquires ThermoKey to meet soaring AI data center demand for cooling and power infrastructure.

VRTAIPO
Benzinga

SEALSQ to Acquire Quantum Interconnect Firm Miraex in Strategic Stack Play

SEALSQ signs Letter of Intent to acquire Swiss quantum interconnect firm Miraex, completing its quantum technology stack and supporting space-based quantum infrastructure initiative.

LAESWKEY
Benzinga

VGTEL Eyes Health-Tech Acquisition From 4biddenknowledge in Strategic Bell Rose Deal

VGTEL enters formal discussions with Bell Rose Capital to acquire a pre-revenue health-tech app, with due diligence underway and potential advisory role for Bell Rose's president.

VGTLBELR